Table 1 Baseline characteristics of the patients.
From: Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing
Characteristics | Total (N = 26) | Organoids culture | p | |
|---|---|---|---|---|
Success (12) | Fail (14) | Â | ||
Age (years) | ||||
 ≥60 | 13 | 4 | 9 | p = 0.24 |
 <60 | 13 | 8 | 5 |  |
Sex |  |  |  | p = 0.68 |
 Male | 18 | 9 | 9 |  |
 Female | 8 | 3 | 5 |  |
Differentiation |  |  |  | p = 0.27 |
 Middle–High | 13 | 4 | 8 |  |
 Low | 13 | 8 | 6 |  |
Subtype |  |  |  | P > 0.99 |
 SRCC | 8 | 4 | 4 |  |
 Non-SRCC | 18 | 8 | 10 |  |
TNM stage |  |  |  | p = 0.17 |
 I–II | 6 | 1 | 5 |  |
 III–IV | 20 | 11 | 9 |  |
